Cite

Impact of measuring heteroplasmy of a pathogenic mitochondrial <scp>DNA</scp> variant at the single‐cell level in individuals with mitochondrial disease

MLA

Atsuko Imai‐Okazaki, et al. “Impact of Measuring Heteroplasmy of a Pathogenic Mitochondrial DNA Variant at the Single‐cell Level in Individuals with Mitochondrial Disease.” Journal of Inherited Metabolic Disease, vol. 45, Sept. 2022, pp. 1143–50. EBSCOhost, https://doi.org/10.1002/jimd.12547.



APA

Atsuko Imai‐Okazaki, Kazuhiro R. Nitta, Yukiko Yatsuka, Ayumu Sugiura, Masato Arao, Masaru Shimura, Tomohiro Ebihara, Takanori Onuki, Keiko Ichimoto, Akira Ohtake, Kei Murayama, & Yasushi Okazaki. (2022). Impact of measuring heteroplasmy of a pathogenic mitochondrial DNA variant at the single‐cell level in individuals with mitochondrial disease. Journal of Inherited Metabolic Disease, 45, 1143–1150. https://doi.org/10.1002/jimd.12547



Chicago

Atsuko Imai‐Okazaki, Kazuhiro R. Nitta, Yukiko Yatsuka, Ayumu Sugiura, Masato Arao, Masaru Shimura, Tomohiro Ebihara, et al. 2022. “Impact of Measuring Heteroplasmy of a Pathogenic Mitochondrial DNA Variant at the Single‐cell Level in Individuals with Mitochondrial Disease.” Journal of Inherited Metabolic Disease 45 (September): 1143–50. doi:10.1002/jimd.12547.